This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanke, C. J. Articles by Campbell, W. B. Search for Related Content PubMed PubMed Citation Articles by Hanke, C. J. Articles by Campbell, W. B.

Nitric Oxide Inhibits Aldosterone Synthesis by a Guanylyl Cyclase-Independent Effect¹

Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226

Address all correspondence and requests for reprints to: William B. Campbell, Ph.D., Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226. E-mail: wbcamp{at}mcw.edu

To investigate the mechanism of nitric oxide (NO) inhibition of aldosterone release, this study compared the effects of type A natriuretic peptide and heat-stable enterotoxin to a nitric oxide donor, deta nonoate, on cGMP production and angiotensin II-stimulated aldosterone synthesis in primary cultures of bovine adrenal zona glomerulosa cells. Type A natriuretic peptide (10^-10-10^-6 M) and deta nonoate (10^-6-10^-3 M) stimulated concentration-related increases in cGMP production. Heat-stable enterotoxin (10^-6 M) failed to stimulate cGMP synthesis in zona glomerulosa cells. Type A natriuretic peptide and deta nonoate attenuated angiotensin II-stimulated aldosterone production over the same concentration range that stimulated cGMP production. Heat-stable enterotoxin (10^-6 M) was without effect on aldosterone release. To further test the hypothesis that cGMP mediated the inhibition of aldosterone synthesis, the selective inhibitor of soluble guanylyl cyclase, 1H-(1,2,4)oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) was used. ODQ pretreatment (10^-5 M) completely prevented deta nonoate-stimulated cGMP production without altering the inhibitory effect of deta nonoate on angiotensin II-stimulated steroidogenesis. Consistent with its selectivity for inhibiting soluble guanylyl cyclase, ODQ did not block type A natriuretic peptide-stimulated cGMP synthesis or type A natriuretic peptide inhibition of steroidogenesis. Deta nonoate completely blocked 25-hydroxycholesterol- and progesterone-stimulated aldosterone synthesis in zona glomerulosa cells and inhibited the conversion of 25-hydroxycholesterol to pregnenolone in mitochondrial fractions from bovine adrenal cortex. Deta nonoate-derived NO gave an absorbance maximum of the mitochondrial cytochrome P450 of 453 nm and inhibited the absorbance at 450 nm caused by carbon monoxide binding to the enzyme. These results suggest that deta nonoate reduces steroidogenesis independent of guanylyl cyclase activation and that NO has a direct effect to inhibit the activity of cytochrome P450, probably by binding to the heme groups of the cytochrome.

This article has been cited by other articles:

				C. J. Hanke, B. B. Holmes, Y. Xu, K. Nithipatikom, and W. B. Campbell Endothelium-Derived Steroidogenic Factor Enhances Angiotensin II-Stimulated Aldosterone Release by Bovine Zona Glomerulosa Cells Endocrinology, January 1, 2007; 148(1): 317 - 323. [Abstract] [Full Text] [PDF]

				C. J. Hanke and A. C. Bauer-Dantoin Teaching aldosterone regulation and basic scientific principles using a classic paper by Dr. James O. Davis and colleagues Advan Physiol Educ, December 1, 2006; 30(4): 141 - 144. [Abstract] [Full Text] [PDF]

				E. M. Repetto, V. Pannunzio, F. Astort, C. Martinez Calejman, M. B. Moreno, O. P. Pignataro, and C. B. Cymeryng Characterization of L-arginine transport in adrenal cells: effect of ACTH Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E291 - E297. [Abstract] [Full Text] [PDF]

				D. X. Zhang, K. M. Gauthier, and W. B. Campbell Mechanisms of histamine-induced relaxation in bovine small adrenal cortical arteries Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1058 - E1063. [Abstract] [Full Text] [PDF]

				F.-J. Lai, S.-S. Huang, M.-C. Hsieh, S.-C. Hsin, C.-H. Wu, Y.-C. Hsin, and S.-J. Shin Upregulation of Neuronal Nitric Oxide Synthase mRNA and Protein in Adrenal Medulla of Water-deprived Rats J. Histochem. Cytochem., January 1, 2005; 53(1): 45 - 53. [Abstract] [Full Text] [PDF]

				K. Nithipatikom, B. B. Holmes, M. J. McCoy, C. J. Hillard, and W. B. Campbell Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E820 - E827. [Abstract] [Full Text] [PDF]

				J. A.S. Muldowney III, S. N. Davis, D. E. Vaughan, and N. J. Brown NO Synthase Inhibition Increases Aldosterone in Humans Hypertension, November 1, 2004; 44(5): 739 - 745. [Abstract] [Full Text] [PDF]

				S. Gambaryan, E. Butt, K. Marcus, M. Glazova, A. Palmetshofer, G. Guillon, and A. Smolenski cGMP-dependent Protein Kinase Type II Regulates Basal Level of Aldosterone Production by Zona Glomerulosa Cells without Increasing Expression of the Steroidogenic Acute Regulatory Protein Gene J. Biol. Chem., August 8, 2003; 278(32): 29640 - 29648. [Abstract] [Full Text] [PDF]

				C. B. Cymeryng, S. P. Lotito, C. Colonna, C. Finkielstein, Y. Pomeraniec, N. Grion, L. Gadda, P. Maloberti, and E. J. Podesta Expression of Nitric Oxide Synthases in Rat Adrenal Zona Fasciculata Cells Endocrinology, April 1, 2002; 143(4): 1235 - 1242. [Abstract] [Full Text] [PDF]

				J. K. Peterson, F. Moran, A. J. Conley, and I. M. Bird Zonal Expression of Endothelial Nitric Oxide Synthase in Sheep and Rhesus Adrenal Cortex Endocrinology, December 1, 2001; 142(12): 5351 - 5363. [Abstract] [Full Text] [PDF]

				E. T. Morgan, V. Ullrich, A. Daiber, P. Schmidt, N. Takaya, H. Shoun, J. C. McGiff, A. Oyekan, C. J. Hanke, W. B. Campbell, et al. Cytochromes P450 and Flavin Monooxygenases---Targets and Sources of Nitric Oxide Drug Metab. Dispos., November 1, 2001; 29(11): 1366 - 1376. [Abstract] [Full Text] [PDF]

				J. A. Florian, A. Dorrance, R. C. Webb, and S. W. Watts Mineralocorticoids upregulate arterial contraction to epidermal growth factor Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R878 - R886. [Abstract] [Full Text] [PDF]

				E. SEELIGER, P. B. PERSSON, W. BOEMKE, G. MOLLENHAUER, B. NAFZ, and H. W. REINHARDT Low-Dose Nitric Oxide Inhibition Produces a Negative Sodium Balance in Conscious Dogs J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1128 - 1136. [Abstract] [Full Text]

				R. Salemi, J. G. McDougall, K. J. Hardy, and E. M. Wintour Local inhibition of nitric oxide temporarily stimulates aldosterone secretion in conscious sheep in vivo Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E584 - E590. [Abstract] [Full Text] [PDF]

				C. J. Hanke and W. B. Campbell Endothelial cell nitric oxide inhibits aldosterone synthesis in zona glomerulosa cells: modulation by oxygen Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E846 - E854. [Abstract] [Full Text] [PDF]

				J. J. Jaroszewski and W. Hansel Intraluteal Administration of a Nitric Oxide Synthase Blocker Stimulates Progesterone and Oxytocin Secretion and Prolongs the Life Span of the Bovine Corpus Luteum Experimental Biology and Medicine, May 1, 2000; 224(1): 50 - 55. [Abstract] [Full Text]

				C. L. Coulter, D. A. Myers, P. W. Nathanielsz, and I. M. Bird Ontogeny of Angiotensin II Type 1 Receptor and Cytochrome P450c11 in the Sheep Adrenal Gland Biol Reprod, March 1, 2000; 62(3): 714 - 719. [Abstract] [Full Text]

				C. J. Hanke, T. O'Brien, K. A. Pritchard Jr, and W. B. Campbell Inhibition of Adrenal Cell Aldosterone Synthesis by Endogenous Nitric Oxide Release Hypertension, January 1, 2000; 35(1): 324 - 328. [Abstract] [Full Text] [PDF]

				L. J. Rosolowsky, C. J. Hanke, and W. B. Campbell Adrenal Capillary Endothelial Cells Stimulate Aldosterone Release through a Protein That Is Distinct from Endothelin Endocrinology, October 1, 1999; 140(10): 4411 - 4418. [Abstract] [Full Text]

				G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF]

				C. B. Cymeryng, L. A. Dada, C. Colonna, C. F. Mendez, and E. J. Podestá Effects of L-Arginine in Rat Adrenal Cells: Involvement of Nitric Oxide Synthase Endocrinology, July 1, 1999; 140(7): 2962 - 2967. [Abstract] [Full Text]